ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,172Medicare Part D Prescriptions Filled, Including Refills

Rank: 278 out of 2343

$601K Total Retail Price of All Prescriptions

Rank: 476 out of 2343

580 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 580 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,173 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 891 731 1 3
OMEPRAZOLE 881 638 2 4
AMLODIPINE BESYLATE 736 597 3 5
BISOPROLOL-HYDROCHLOROTHIAZIDE 564 448 4 151
NAPROXEN 523 407 5 108
SIMVASTATIN 473 384 6 1
METFORMIN HCL 420 316 7 9
FUROSEMIDE 391 335 8 6
FLUTICASONE PROPIONATE 293 202 9 46
LOSARTAN POTASSIUM 261 183 10 19
TAMSULOSIN HCL 250 185 11 29
AZELASTINE HCL 249 191 12 338
HYDROCHLOROTHIAZIDE 241 201 13 11
JANUVIA 220 161 14 50
LOVASTATIN 213 183 15 47
LEVOTHYROXINE SODIUM 178 121 16 2
FINASTERIDE 154 137 17 80
PREDNISONE 151 118 18 37
WARFARIN SODIUM 142 125 19 8
ATENOLOL 139 130 20 12
DOXAZOSIN MESYLATE 136 103 21 98
PRAVASTATIN SODIUM 136 95 21 15
ACTOS 135 120 23 125
ALLOPURINOL 131 103 24 31
BYSTOLIC 128 104 25 123
LOSARTAN-HYDROCHLOROTHIAZIDE 103 88 26 64
CLONIDINE HCL 102 90 27 70
ACETAMINOPHEN-CODEINE 102 87 S3 27 112
VENTOLIN HFA 98 61 29 79
ZETIA 95 52 30 52
TRAMADOL HCL 92 37 31 25
GABAPENTIN 89 46 32 16
DIOVAN 88 77 33 23
ATORVASTATIN CALCIUM 88 64 33 10
HYDROCODONE-ACETAMINOPHEN 85 45 S3 35 13
CALCITRIOL 83 71 36 189
GLIMEPIRIDE 81 75 37 45
NIFEDIPINE ER 80 76 38 89
NAMENDA 78 67 39 36
TERAZOSIN HCL 76 59 40 143
QUINAPRIL HCL 73 69 41 73
METFORMIN HCL ER 72 59 42 88
PLAVIX 69 66 43 38
CYCLOBENZAPRINE HCL 69 41 R 43 109
POTASSIUM CHLORIDE 66 55 45 18
ISOSORBIDE MONONITRATE ER 65 48 46 32
CLOPIDOGREL 62 52 47 26
IBUPROFEN 62 42 47 75
ZOLPIDEM TARTRATE 61 51 49 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 24 50 42
PIOGLITAZONE HCL 58 52 R 51 347
COMBIVENT 57 48 52 144
VESICARE 56 56 53 145
AMLODIPINE BESYLATE-BENAZEPRIL 55 49 54 59
METOPROLOL TARTRATE 53 30 55 7
DILTIAZEM ER 51 48 56 207
NIFEDICAL XL 50 42 57 148
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.